Featured Research

from universities, journals, and other organizations

MIT Study May Lead To Powerful New Painkillers

Date:
April 5, 2002
Source:
Massachusetts Institute Of Technology
Summary:
New information on a cellular messenger may lead to powerful new painkilling drugs, Massachusetts Institute of Technology researchers recently reported online in the journal Psychopharmacology.

CAMBRIDGE, Mass. — New information on a cellular messenger may lead to powerful new painkilling drugs, Massachusetts Institute of Technology researchers recently reported online in the journal Psychopharmacology.

Blocking a common signaling messenger between cells might shut down the chronic pain and inflammation that plagues millions, says author Lisa A. Teather, postdoctoral associate in the MIT Department of Brain and Cognitive Sciences.

More than 100 million North Americans suffer from chronic pain, and around half of these people are partially or totally disabled by it. Inflammation may also be involved in the pathology of diseases such as Alzheimer’s.

Teather studies platelet-activating factor (PAF), identified as a blood-clotting agent in the 1970s. It was later found to cause the buildup of prostaglandins, derivatives of fatty acids found in most body tissues. Excess prostaglandins are associated with chronic pain and inflammation.

AN INSIDE STORY

PAF affects two kinds of receptors. Teather believes that receptors within cells regulate prostaglandin production. Drugs such as ibuprofen and aspirin relieve pain by blocking the formation of prostaglandins.

Teather and co-authors Richard J. Wurtman, C. H. Green Distinguished Professor in Brain and Cognitive Sciences and director of MIT’s Clinical Research Center; and Jane E. Magnusson of the Department of Clinical Neurosciences at the University of Calgary, found that drugs that interfere with PAF’s action block prostaglandin production and diminish pain and inflammation.

Although these drugs are not now used to treat inflammation or pain, one is in the herbal supplement gingko biloba. MIT has filed for patents on blocking PAF as a means for mediating inflammatory responses and alleviating pain.

In the study, rats that were given drugs known to block PAF action exhibited significantly less pain response than did rats that did not get the drugs.

Although the researchers do not yet have any data on PAF in humans, they believe that blocking PAF might be effective in the treatment of certain forms of acute and chronic pain.

CHECKING IMMUNE RESPONSE

"PAF controls many of the usual suspects in the inflammatory reaction," Teather said. Out-of-control inflammation is an indication of an immune response gone awry. At a molecular level, an overactive immune system leads to neurotoxicity, which may be a culprit in some neurological diseases.

A future painkiller that regulates PAF also could be useful in conjunction with morphine, which quickly loses its effectiveness in patients with chronic pain.

This study was supported in part by grants from the National Institutes of Mental Health and the Center for Brain Sciences and Metabolism Charitable Trust.


Story Source:

The above story is based on materials provided by Massachusetts Institute Of Technology. Note: Materials may be edited for content and length.


Cite This Page:

Massachusetts Institute Of Technology. "MIT Study May Lead To Powerful New Painkillers." ScienceDaily. ScienceDaily, 5 April 2002. <www.sciencedaily.com/releases/2002/04/020402073407.htm>.
Massachusetts Institute Of Technology. (2002, April 5). MIT Study May Lead To Powerful New Painkillers. ScienceDaily. Retrieved July 24, 2014 from www.sciencedaily.com/releases/2002/04/020402073407.htm
Massachusetts Institute Of Technology. "MIT Study May Lead To Powerful New Painkillers." ScienceDaily. www.sciencedaily.com/releases/2002/04/020402073407.htm (accessed July 24, 2014).

Share This




More Health & Medicine News

Thursday, July 24, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

New Painkiller Designed To Discourage Abuse: Will It Work?

New Painkiller Designed To Discourage Abuse: Will It Work?

Newsy (July 24, 2014) The FDA approved Targiniq ER on Wednesday, a painkiller designed to keep users from abusing it. Like any new medication, however, it has doubters. Video provided by Newsy
Powered by NewsLook.com
Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Newsy (July 24, 2014) Sheik Umar Khan has treated many of the people infected in the Ebola outbreak, and now he's become one of them. Video provided by Newsy
Powered by NewsLook.com
Condemned Man's US Execution Takes Nearly Two Hours

Condemned Man's US Execution Takes Nearly Two Hours

AFP (July 24, 2014) America's death penalty debate raged Thursday after it took nearly two hours for Arizona to execute a prisoner who lost a Supreme Court battle challenging the experimental lethal drug cocktail. Duration: 00:55 Video provided by AFP
Powered by NewsLook.com
China's Ageing Millions Look Forward to Bleak Future

China's Ageing Millions Look Forward to Bleak Future

AFP (July 24, 2014) China's elderly population is expanding so quickly that children struggle to look after them, pushing them to do something unexpected in Chinese society- move their parents into a nursing home. Duration: 02:07 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins